ACTEMRA conc perf 400 mg/20 ml flac 20 ml
7680588680035
CH-58868
L04AC07
07.15.0.
Reimbursement limitations:
ACTEMRA6
Le traitement avec Actemra exige une garantie préalable de prise en charge des frais par …
1 / 2
google
Details
- Product number
- 5886803
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- tocilizumabum 400 mg, polysorbatum 80, saccharum, dinatrii phosphas dodecahydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 8.84 mg.
Articles (1)
Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.84 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 722.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2009
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 58868
- Drug name
- Actemra, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L04AC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/12/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ACTEMRA conc perf 400 mg/20 ml flac 20 ml
- Description (DE)
- ACTEMRA Inf Konz 400 mg/20 ml Durchstf 20 ml
- Market launch
- 02/12/2008
- Narcotic (BTM)
- No